Global Nonalcoholic Steatohepatitis (Nash) Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
Based on the Nonalcoholic Steatohepatitis (Nash) market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Nonalcoholic Steatohepatitis (Nash) market covered in Chapter 5:
Genfit
Novo Nordisk
Gilead Science
Boehringer Ingelheim
Viking Therapeutics
Connexios Life Sciences
Tobira Therapeutics, Inc.
Galmed Pharmaceuticals Ltd.
Nimbus Therapeutics
Verva Pharmaceuticals
Cerenis Therapeutics
GENFIT SA
Islet Sciences
Immuron Ltd
Enzo Biochem, Inc
Astazeneca Plc
Intercepts Pharmaceuticals
In Chapter 6, on the basis of types, the Nonalcoholic Steatohepatitis (Nash) market from 2015 to 2025 is primarily split into:
Weight Loss Treatment
Insulin-Sensitizing Agents
Lipid-Lowering Drugs
Antioxidants
Other Agents
In Chapter 7, on the basis of applications, the Nonalcoholic Steatohepatitis (Nash) market from 2015 to 2025 covers:
Phase I
Phase II
Phase III
Clinical Trials
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Nonalcoholic Steatohepatitis (Nash) Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Genfit
5.1.1 Genfit Company Profile
5.1.2 Genfit Business Overview
5.1.3 Genfit Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Genfit Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.2 Novo Nordisk
5.2.1 Novo Nordisk Company Profile
5.2.2 Novo Nordisk Business Overview
5.2.3 Novo Nordisk Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Novo Nordisk Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.3 Gilead Science
5.3.1 Gilead Science Company Profile
5.3.2 Gilead Science Business Overview
5.3.3 Gilead Science Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Gilead Science Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.4 Boehringer Ingelheim
5.4.1 Boehringer Ingelheim Company Profile
5.4.2 Boehringer Ingelheim Business Overview
5.4.3 Boehringer Ingelheim Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Boehringer Ingelheim Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.5 Viking Therapeutics
5.5.1 Viking Therapeutics Company Profile
5.5.2 Viking Therapeutics Business Overview
5.5.3 Viking Therapeutics Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Viking Therapeutics Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.6 Connexios Life Sciences
5.6.1 Connexios Life Sciences Company Profile
5.6.2 Connexios Life Sciences Business Overview
5.6.3 Connexios Life Sciences Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Connexios Life Sciences Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.7 Tobira Therapeutics, Inc.
5.7.1 Tobira Therapeutics, Inc. Company Profile
5.7.2 Tobira Therapeutics, Inc. Business Overview
5.7.3 Tobira Therapeutics, Inc. Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Tobira Therapeutics, Inc. Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.8 Galmed Pharmaceuticals Ltd.
5.8.1 Galmed Pharmaceuticals Ltd. Company Profile
5.8.2 Galmed Pharmaceuticals Ltd. Business Overview
5.8.3 Galmed Pharmaceuticals Ltd. Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Galmed Pharmaceuticals Ltd. Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.9 Nimbus Therapeutics
5.9.1 Nimbus Therapeutics Company Profile
5.9.2 Nimbus Therapeutics Business Overview
5.9.3 Nimbus Therapeutics Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Nimbus Therapeutics Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.10 Verva Pharmaceuticals
5.10.1 Verva Pharmaceuticals Company Profile
5.10.2 Verva Pharmaceuticals Business Overview
5.10.3 Verva Pharmaceuticals Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Verva Pharmaceuticals Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.11 Cerenis Therapeutics
5.11.1 Cerenis Therapeutics Company Profile
5.11.2 Cerenis Therapeutics Business Overview
5.11.3 Cerenis Therapeutics Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Cerenis Therapeutics Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.12 GENFIT SA
5.12.1 GENFIT SA Company Profile
5.12.2 GENFIT SA Business Overview
5.12.3 GENFIT SA Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 GENFIT SA Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.13 Islet Sciences
5.13.1 Islet Sciences Company Profile
5.13.2 Islet Sciences Business Overview
5.13.3 Islet Sciences Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Islet Sciences Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.14 Immuron Ltd
5.14.1 Immuron Ltd Company Profile
5.14.2 Immuron Ltd Business Overview
5.14.3 Immuron Ltd Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Immuron Ltd Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.15 Enzo Biochem, Inc
5.15.1 Enzo Biochem, Inc Company Profile
5.15.2 Enzo Biochem, Inc Business Overview
5.15.3 Enzo Biochem, Inc Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 Enzo Biochem, Inc Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.16 Astazeneca Plc
5.16.1 Astazeneca Plc Company Profile
5.16.2 Astazeneca Plc Business Overview
5.16.3 Astazeneca Plc Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 Astazeneca Plc Nonalcoholic Steatohepatitis (Nash) Products Introduction
5.17 Intercepts Pharmaceuticals
5.17.1 Intercepts Pharmaceuticals Company Profile
5.17.2 Intercepts Pharmaceuticals Business Overview
5.17.3 Intercepts Pharmaceuticals Nonalcoholic Steatohepatitis (Nash) Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.17.4 Intercepts Pharmaceuticals Nonalcoholic Steatohepatitis (Nash) Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Nonalcoholic Steatohepatitis (Nash) Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Nonalcoholic Steatohepatitis (Nash) Sales and Market Share by Types (2015-2020)
6.1.2 Global Nonalcoholic Steatohepatitis (Nash) Revenue and Market Share by Types (2015-2020)
6.1.3 Global Nonalcoholic Steatohepatitis (Nash) Price by Types (2015-2020)
6.2 Global Nonalcoholic Steatohepatitis (Nash) Market Forecast by Types (2020-2025)
6.2.1 Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Nonalcoholic Steatohepatitis (Nash) Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Nonalcoholic Steatohepatitis (Nash) Sales, Price and Growth Rate of Weight Loss Treatment
6.3.2 Global Nonalcoholic Steatohepatitis (Nash) Sales, Price and Growth Rate of Insulin-Sensitizing Agents
6.3.3 Global Nonalcoholic Steatohepatitis (Nash) Sales, Price and Growth Rate of Lipid-Lowering Drugs
6.3.4 Global Nonalcoholic Steatohepatitis (Nash) Sales, Price and Growth Rate of Antioxidants
6.3.5 Global Nonalcoholic Steatohepatitis (Nash) Sales, Price and Growth Rate of Other Agents
6.4 Global Nonalcoholic Steatohepatitis (Nash) Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Weight Loss Treatment Market Revenue and Sales Forecast (2020-2025)
6.4.2 Insulin-Sensitizing Agents Market Revenue and Sales Forecast (2020-2025)
6.4.3 Lipid-Lowering Drugs Market Revenue and Sales Forecast (2020-2025)
6.4.4 Antioxidants Market Revenue and Sales Forecast (2020-2025)
6.4.5 Other Agents Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Nonalcoholic Steatohepatitis (Nash) Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Nonalcoholic Steatohepatitis (Nash) Sales and Market Share by Applications (2015-2020)
7.1.2 Global Nonalcoholic Steatohepatitis (Nash) Revenue and Market Share by Applications (2015-2020)
7.2 Global Nonalcoholic Steatohepatitis (Nash) Market Forecast by Applications (2020-2025)
7.2.1 Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Nonalcoholic Steatohepatitis (Nash) Revenue, Sales and Growth Rate of Phase I (2015-2020)
7.3.2 Global Nonalcoholic Steatohepatitis (Nash) Revenue, Sales and Growth Rate of Phase II (2015-2020)
7.3.3 Global Nonalcoholic Steatohepatitis (Nash) Revenue, Sales and Growth Rate of Phase III (2015-2020)
7.3.4 Global Nonalcoholic Steatohepatitis (Nash) Revenue, Sales and Growth Rate of Clinical Trials (2015-2020)
7.4 Global Nonalcoholic Steatohepatitis (Nash) Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Phase I Market Revenue and Sales Forecast (2020-2025)
7.4.2 Phase II Market Revenue and Sales Forecast (2020-2025)
7.4.3 Phase III Market Revenue and Sales Forecast (2020-2025)
7.4.4 Clinical Trials Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Nonalcoholic Steatohepatitis (Nash) Sales by Regions (2015-2020)
8.2 Global Nonalcoholic Steatohepatitis (Nash) Market Revenue by Regions (2015-2020)
8.3 Global Nonalcoholic Steatohepatitis (Nash) Market Forecast by Regions (2020-2025)
9 North America Nonalcoholic Steatohepatitis (Nash) Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
9.3 North America Nonalcoholic Steatohepatitis (Nash) Market Revenue and Growth Rate (2015-2020)
9.4 North America Nonalcoholic Steatohepatitis (Nash) Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Nonalcoholic Steatohepatitis (Nash) Market Analysis by Country
9.6.1 U.S. Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
9.6.2 Canada Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
9.6.3 Mexico Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
10 Europe Nonalcoholic Steatohepatitis (Nash) Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
10.3 Europe Nonalcoholic Steatohepatitis (Nash) Market Revenue and Growth Rate (2015-2020)
10.4 Europe Nonalcoholic Steatohepatitis (Nash) Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Nonalcoholic Steatohepatitis (Nash) Market Analysis by Country
10.6.1 Germany Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
10.6.2 United Kingdom Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
10.6.3 France Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
10.6.4 Italy Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
10.6.5 Spain Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
10.6.6 Russia Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
11 Asia-Pacific Nonalcoholic Steatohepatitis (Nash) Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Nonalcoholic Steatohepatitis (Nash) Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Nonalcoholic Steatohepatitis (Nash) Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Nonalcoholic Steatohepatitis (Nash) Market Analysis by Country
11.6.1 China Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
11.6.2 Japan Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
11.6.3 South Korea Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
11.6.4 Australia Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
11.6.5 India Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
12 South America Nonalcoholic Steatohepatitis (Nash) Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
12.3 South America Nonalcoholic Steatohepatitis (Nash) Market Revenue and Growth Rate (2015-2020)
12.4 South America Nonalcoholic Steatohepatitis (Nash) Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Nonalcoholic Steatohepatitis (Nash) Market Analysis by Country
12.6.1 Brazil Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
12.6.2 Argentina Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
12.6.3 Columbia Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
13 Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Market Analysis by Country
13.6.1 UAE Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
13.6.2 Egypt Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
13.6.3 South Africa Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
List of Tables and Figures
Figure Product Picture
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Size and Growth Rate 2015-2025
Table Nonalcoholic Steatohepatitis (Nash) Key Market Segments
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Revenue ($) Segment by Type from 2015-2020
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Nonalcoholic Steatohepatitis (Nash)
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Genfit Company Profile
Table Genfit Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Genfit Production and Growth Rate
Figure Genfit Market Revenue ($) Market Share 2015-2020
Table Novo Nordisk Company Profile
Table Novo Nordisk Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novo Nordisk Production and Growth Rate
Figure Novo Nordisk Market Revenue ($) Market Share 2015-2020
Table Gilead Science Company Profile
Table Gilead Science Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Gilead Science Production and Growth Rate
Figure Gilead Science Market Revenue ($) Market Share 2015-2020
Table Boehringer Ingelheim Company Profile
Table Boehringer Ingelheim Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Boehringer Ingelheim Production and Growth Rate
Figure Boehringer Ingelheim Market Revenue ($) Market Share 2015-2020
Table Viking Therapeutics Company Profile
Table Viking Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Viking Therapeutics Production and Growth Rate
Figure Viking Therapeutics Market Revenue ($) Market Share 2015-2020
Table Connexios Life Sciences Company Profile
Table Connexios Life Sciences Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Connexios Life Sciences Production and Growth Rate
Figure Connexios Life Sciences Market Revenue ($) Market Share 2015-2020
Table Tobira Therapeutics, Inc. Company Profile
Table Tobira Therapeutics, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Tobira Therapeutics, Inc. Production and Growth Rate
Figure Tobira Therapeutics, Inc. Market Revenue ($) Market Share 2015-2020
Table Galmed Pharmaceuticals Ltd. Company Profile
Table Galmed Pharmaceuticals Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Galmed Pharmaceuticals Ltd. Production and Growth Rate
Figure Galmed Pharmaceuticals Ltd. Market Revenue ($) Market Share 2015-2020
Table Nimbus Therapeutics Company Profile
Table Nimbus Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Nimbus Therapeutics Production and Growth Rate
Figure Nimbus Therapeutics Market Revenue ($) Market Share 2015-2020
Table Verva Pharmaceuticals Company Profile
Table Verva Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Verva Pharmaceuticals Production and Growth Rate
Figure Verva Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Cerenis Therapeutics Company Profile
Table Cerenis Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Cerenis Therapeutics Production and Growth Rate
Figure Cerenis Therapeutics Market Revenue ($) Market Share 2015-2020
Table GENFIT SA Company Profile
Table GENFIT SA Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure GENFIT SA Production and Growth Rate
Figure GENFIT SA Market Revenue ($) Market Share 2015-2020
Table Islet Sciences Company Profile
Table Islet Sciences Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Islet Sciences Production and Growth Rate
Figure Islet Sciences Market Revenue ($) Market Share 2015-2020
Table Immuron Ltd Company Profile
Table Immuron Ltd Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Immuron Ltd Production and Growth Rate
Figure Immuron Ltd Market Revenue ($) Market Share 2015-2020
Table Enzo Biochem, Inc Company Profile
Table Enzo Biochem, Inc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Enzo Biochem, Inc Production and Growth Rate
Figure Enzo Biochem, Inc Market Revenue ($) Market Share 2015-2020
Table Astazeneca Plc Company Profile
Table Astazeneca Plc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Astazeneca Plc Production and Growth Rate
Figure Astazeneca Plc Market Revenue ($) Market Share 2015-2020
Table Intercepts Pharmaceuticals Company Profile
Table Intercepts Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Intercepts Pharmaceuticals Production and Growth Rate
Figure Intercepts Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Global Nonalcoholic Steatohepatitis (Nash) Sales by Types (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Sales Share by Types (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Revenue ($) by Types (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Revenue Share by Types (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Price ($) by Types (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Sales by Types (2020-2025)
Table Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Sales Share by Types (2020-2025)
Table Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Revenue ($) by Types (2020-2025)
Table Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Revenue Share by Types (2020-2025)
Figure Global Weight Loss Treatment Sales and Growth Rate (2015-2020)
Figure Global Weight Loss Treatment Price (2015-2020)
Figure Global Insulin-Sensitizing Agents Sales and Growth Rate (2015-2020)
Figure Global Insulin-Sensitizing Agents Price (2015-2020)
Figure Global Lipid-Lowering Drugs Sales and Growth Rate (2015-2020)
Figure Global Lipid-Lowering Drugs Price (2015-2020)
Figure Global Antioxidants Sales and Growth Rate (2015-2020)
Figure Global Antioxidants Price (2015-2020)
Figure Global Other Agents Sales and Growth Rate (2015-2020)
Figure Global Other Agents Price (2015-2020)
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Revenue ($) and Growth Rate Forecast of Weight Loss Treatment (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate Forecast of Weight Loss Treatment (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Revenue ($) and Growth Rate Forecast of Insulin-Sensitizing Agents (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate Forecast of Insulin-Sensitizing Agents (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Revenue ($) and Growth Rate Forecast of Lipid-Lowering Drugs (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate Forecast of Lipid-Lowering Drugs (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Revenue ($) and Growth Rate Forecast of Antioxidants (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate Forecast of Antioxidants (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Revenue ($) and Growth Rate Forecast of Other Agents (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate Forecast of Other Agents (2020-2025)
Table Global Nonalcoholic Steatohepatitis (Nash) Sales by Applications (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Sales Share by Applications (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Revenue ($) by Applications (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Revenue Share by Applications (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Sales by Applications (2020-2025)
Table Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Sales Share by Applications (2020-2025)
Table Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Phase I Sales and Growth Rate (2015-2020)
Figure Global Phase I Price (2015-2020)
Figure Global Phase II Sales and Growth Rate (2015-2020)
Figure Global Phase II Price (2015-2020)
Figure Global Phase III Sales and Growth Rate (2015-2020)
Figure Global Phase III Price (2015-2020)
Figure Global Clinical Trials Sales and Growth Rate (2015-2020)
Figure Global Clinical Trials Price (2015-2020)
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Revenue ($) and Growth Rate Forecast of Phase I (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate Forecast of Phase I (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Revenue ($) and Growth Rate Forecast of Phase II (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate Forecast of Phase II (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Revenue ($) and Growth Rate Forecast of Phase III (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate Forecast of Phase III (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Market Revenue ($) and Growth Rate Forecast of Clinical Trials (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate Forecast of Clinical Trials (2020-2025)
Figure Global Nonalcoholic Steatohepatitis (Nash) Sales and Growth Rate (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Sales by Regions (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Sales Market Share by Regions (2015-2020)
Figure Global Nonalcoholic Steatohepatitis (Nash) Sales Market Share by Regions in 2019
Figure Global Nonalcoholic Steatohepatitis (Nash) Revenue and Growth Rate (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Revenue by Regions (2015-2020)
Table Global Nonalcoholic Steatohepatitis (Nash) Revenue Market Share by Regions (2015-2020)
Figure Global Nonalcoholic Steatohepatitis (Nash) Revenue Market Share by Regions in 2019
Table Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Sales by Regions (2020-2025)
Table Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Sales Share by Regions (2020-2025)
Table Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Nonalcoholic Steatohepatitis (Nash) Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure North America Nonalcoholic Steatohepatitis (Nash) Market Revenue and Growth Rate (2015-2020)
Figure North America Nonalcoholic Steatohepatitis (Nash) Market Forecast Sales (2020-2025)
Figure North America Nonalcoholic Steatohepatitis (Nash) Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure Canada Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure Mexico Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure Europe Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure Europe Nonalcoholic Steatohepatitis (Nash) Market Revenue and Growth Rate (2015-2020)
Figure Europe Nonalcoholic Steatohepatitis (Nash) Market Forecast Sales (2020-2025)
Figure Europe Nonalcoholic Steatohepatitis (Nash) Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure France Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure Italy Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure Spain Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure Russia Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Nonalcoholic Steatohepatitis (Nash) Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Nonalcoholic Steatohepatitis (Nash) Market Forecast Sales (2020-2025)
Figure Asia-Pacific Nonalcoholic Steatohepatitis (Nash) Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure Japan Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure South Korea Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure Australia Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure India Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure South America Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure South America Nonalcoholic Steatohepatitis (Nash) Market Revenue and Growth Rate (2015-2020)
Figure South America Nonalcoholic Steatohepatitis (Nash) Market Forecast Sales (2020-2025)
Figure South America Nonalcoholic Steatohepatitis (Nash) Market Forecast Revenue ($) (2020-2025)
Figure Brazil Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure Argentina Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure Columbia Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Market Forecast Sales (2020-2025)
Figure Middle East and Africa Nonalcoholic Steatohepatitis (Nash) Market Forecast Revenue ($) (2020-2025)
Figure UAE Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure Egypt Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Figure South Africa Nonalcoholic Steatohepatitis (Nash) Market Sales and Growth Rate (2015-2020)
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|